Creo device used in 'groundbreaking' lung cancer procedure
1st Mar 2024 14:06
(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.
Read moreCreo Medical FY revenues up double digits
7th Feb 2024 11:49
(Sharecast News) - Medical device company Creo Medical said on Wednesday that 2023 was "a pivotal year" for the firm, with new products supporting "strong growth" and leading to a double-digit jump in group revenues.
Read moreCreo launches 'Speedboat Ultraslim' with first UK procedure
13th Dec 2023 14:28
(Sharecast News) - Creo Medical Group announced a significant milestone for its Speedboat UltraSlim medical device in the field of surgical endoscopy on Wednesday.
Read moreCreo Medical gets US FDA clearance for Speedboat UltraSlim
1st Nov 2023 14:28
(Sharecast News) - Medical device company Creo Medical Group announced on Wednesday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Speedboat UltraSlim device.
Read moreCreo Medical accelerating EU launch of Speedboat UltraSlim
25th Oct 2023 13:44
(Sharecast News) - Creo Medical Group announced the acceleration of its EU launch of the 'Speedboat UltraSlim' device by around 18 months on Wednesday.
Read moreCreo Medical's 'Speedboat Inject' used for first time in Europe
26th Jun 2023 10:35
(Sharecast News) - Surgical endoscopy specialist Creo Medical announced on Monday that Dr Adolfo Parra-Blanco at Nottingham University Hospital NHS Trust had become the first clinician to perform an upper gastrointestinal (GI) tract 'Speedboat Inject' case in Europe, since clearance was gained last week.
Read moreCreo's Speedboat Inject to be evaluated by NICE
1st Jun 2023 15:14
(Sharecast News) - Surgical endoscopy specialist Creo Medical Group announced on Thursday that its 'Speedboat Inject' product had been chosen by the National Institute for Health and Care Excellence (NICE) for further evaluation and guidance in the endoscopic submucosal dissection (ESD) of lower gastrointestinal (GI) lesions.
Read moreCreo Medical achieves second Albyn earn-out target
14th Apr 2023 12:10
(Sharecast News) - Creo Medical Group announced on Friday that it has successfully achieved the earn-out target for the 12 months ended July last year, over the acquisition of Albyn Medical.
Read moreCreo raising at least £25m to progress various programmes
16th Feb 2023 18:19
(Sharecast News) - Medical device developer Creo Medical Group announced a fundraising of at least £25m net of expenses on Thursday, to progress its electrosurgical device programmes.
Read moreCreo Medical signs IP licence deal with CMR Surgical
24th Oct 2022 15:04
(Sharecast News) - Surgical endoscopy device company Creo Medical Group has signed a non-exclusive intellectual property licence and a royalty agreement with surgical robotics business CMR Surgical, it announced on Monday, to integrate certain aspects of Creo's technology with the 'Versius' surgical robotic system through its 'powered by Kamaptive' licensing programme.
Read moreCreo Medical ends year with revenue above forecasts
3rd Feb 2022 11:36
(Sharecast News) - Surgical endoscopy medical device company Creo Medical Group said it continued to deliver on its three-tiered 'build, buy and partner' strategy in a trading update on Thursday, saying it built momentum through "sustained commercial progress" in 2021.
Read moreCreo Medical acquires Aber Electronics for undisclosed sum
12th Nov 2021 09:38
(Sharecast News) - Medical device company Creo Medical Group has acquired power amplifier and radio frequency products manufacturer and designer Aber Electronics for an undisclosed, fixed cash consideration, plus a contingent consideration over a three-year period.
Read moreCreo Medical losses widen slightly as products progress
30th Sep 2021 10:00
(Sharecast News) - Surgical endoscopy technology company Creo Medical reported total first-half sales of £12.9m on Thursday, up from nil sales year-on-year.
Read moreCreo Medical opens new US headquarters as it focuses on market
16th Jul 2021 11:27
(Sharecast News) - Surgical endoscopy medical devices company Creo Medical Group has opened its United States headquarters at the Summit in Danbury, Connecticut, it announced on Friday.
Read moreCreo Medical buys freehold on head office and adjacent site
6th Jul 2021 09:22
(Sharecast News) - Surgical endoscopy device company Creo Medical has completed the freehold purchase of its main headquarters in Chepstow, Creo House, it announced on Tuesday.
Read more